See more : Mangalam Organics Limited (MANORG.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Sotera Health Company (SHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sotera Health Company, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Sinochem International Corporation (600500.SS) Income Statement Analysis – Financial Results
- Highlight Communications AG (HLG.DE) Income Statement Analysis – Financial Results
- Diamond Hill Investment Group, Inc. (DHIL) Income Statement Analysis – Financial Results
- Guoanda Co., Ltd. (300902.SZ) Income Statement Analysis – Financial Results
- Nakanishi Inc. (7716.T) Income Statement Analysis – Financial Results
Sotera Health Company (SHC)
About Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 1.05B | 1.00B | 931.48M | 818.16M | 778.33M | 746.15M |
Cost of Revenue | 472.13M | 446.68M | 412.81M | 374.59M | 382.90M | 388.90M |
Gross Profit | 577.16M | 557.00M | 518.67M | 443.57M | 395.43M | 357.25M |
Gross Profit Ratio | 55.00% | 55.50% | 55.68% | 54.22% | 50.81% | 47.88% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133.36M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 236.67M | 245.71M | 198.16M | 178.53M | 147.48M | 133.36M |
Other Expenses | 63.80M | 62.94M | 63.78M | 59.03M | 58.56M | 3.87M |
Operating Expenses | 300.47M | 308.65M | 261.94M | 237.55M | 206.04M | 191.34M |
Cost & Expenses | 772.60M | 755.34M | 674.75M | 612.14M | 588.94M | 580.24M |
Interest Income | 0.00 | 80.14M | 74.19M | 215.26M | 157.73M | 0.00 |
Interest Expense | 142.88M | 80.14M | 74.19M | 215.26M | 157.73M | 143.33M |
Depreciation & Amortization | 160.34M | 147.75M | 153.15M | 145.51M | 148.77M | 148.15M |
EBITDA | 420.20M | -2.99M | 404.25M | 319.96M | 305.25M | 316.60M |
EBITDA Ratio | 40.05% | 31.66% | 36.04% | 33.55% | 44.11% | 42.43% |
Operating Income | 276.69M | 248.35M | 256.73M | 206.02M | 183.60M | 80.85M |
Operating Income Ratio | 26.37% | 24.74% | 27.56% | 25.18% | 23.59% | 10.84% |
Total Other Income/Expenses | -170.67M | -491.46M | -81.02M | -244.88M | -184.51M | -56.63M |
Income Before Tax | 106.03M | -243.11M | 175.72M | -38.86M | -916.00K | 24.22M |
Income Before Tax Ratio | 10.10% | -24.22% | 18.86% | -4.75% | -0.12% | 3.25% |
Income Tax Expense | 54.65M | -9.54M | 58.60M | -1.37M | 19.51M | 30.10M |
Net Income | 51.38M | -233.57M | 116.88M | -37.49M | -20.43M | -5.87M |
Net Income Ratio | 4.90% | -23.27% | 12.55% | -4.58% | -2.62% | -0.79% |
EPS | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
EPS Diluted | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
Weighted Avg Shares Out | 281.01M | 280.10M | 279.23M | 283.25M | 284.42M | 246.15M |
Weighted Avg Shares Out (Dil) | 283.22M | 280.10M | 279.38M | 283.25M | 284.42M | 246.15M |
The Schall Law Firm Encourages Investors In Sotera Health Company With Losses Surpassing $100,000 To Establish Communication
The Schall Law Firm Urges Investors In Sotera Health Company (NASDAQ:SHC) Experiencing Losses Exceeding $100,000 To Initiate Contact
The Schall Law Firm Encourages Investors In Sotera Health Company (NASDAQ:SHC) With Losses Over $100,000 To Establish Communication
The Schall Law Firm Urges Investors In Sotera Health Company (NASDAQ:SHC) Experiencing Losses Exceeding $100,000 To Initiate Contact
The Schall Law Firm Encourages Investors In Sotera Health Company (NASDAQ:SHC) With Losses Over $100,000 To Reach Out
The Schall Law Firm Urges Investors In Sotera Health Company (NASDAQ:SHC) Who Have Incurred Losses Exceeding $100,000 To Make Contact
The Schall Law Firm Encourages Investors In Sotera Health Company (NASDAQ:SHC) Who Have Suffered Losses Surpassing $100,000 To Reach Out
The Schall Law Firm Urges Investors In Sotera Health Company (NASDAQ:SHC) Who Have Incurred Losses Exceeding $100,000 To Make Contact
The Schall Law Firm Encourages Investors In Sotera Health Company (NASDAQ:SHC) Who Have Suffered Losses Surpassing $100,000 To Reach Out
The Schall Law Firm Is Strongly Encouraging Investors In Sotera Health Company (NASDAQ:SHC) Who Have Experienced Losses Over $100,000 To Make Contact
Source: https://incomestatements.info
Category: Stock Reports